Taiho Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Japan
- Registered address
- 200-22, Motohara, Kamikawa-machi, Kodama-gun, Saitama 367-0241, Japan (JPN)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3002646390 · DUNS 695734327
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-10-13
- NAIDrug Quality Assurance2015-05-15
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- trifluridine and tipiracilTaiho Pharmaceutical Co., Ltd.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.